Clinical relevance of high sensitivity C-reactive protein in cardiology

Dalia Adukauskienė1, Aušra Čiginskienė1, Agnė Adukauskaitė2

  • 1Department of Intensive Care, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Insights

High-sensitivity C-reactive protein (hsCRP) is crucial for understanding cardiovascular diseases (CVD). Guidelines now recommend hsCRP testing for both primary and secondary CVD prevention strategies.

Area of Science:

  • Cardiology
  • Clinical Chemistry
  • Inflammation Research

Background:

  • Cardiovascular diseases (CVD) are a leading global cause of mortality.
  • High-sensitivity C-reactive protein (hsCRP) is investigated for its role in CVD pathogenesis, prognosis, and prevention.
  • The inflammatory origin of atherosclerosis is increasingly debated, questioning whether elevated hsCRP is a cause or consequence.

Purpose of the Study:

  • To review the current understanding and clinical application of hsCRP testing in cardiovascular diseases.
  • To summarize controversial data and guideline recommendations regarding hsCRP in CVD management.
  • To explore the role of hsCRP in various cardiovascular conditions and the development of CRP-modulating medications.

Main Methods:

  • Review and synthesis of controversial data from multiple studies.
  • Analysis of current clinical guidelines recommending hsCRP testing.
  • Examination of hsCRP's role in diverse cardiovascular pathologies and treatment efficacy.

Main Results:

  • Guidelines recommend hsCRP testing for primary CVD prevention, including risk stratification and statin therapy selection.
  • hsCRP testing is advised for secondary CVD prevention, aiding prognosis and evaluating treatment efficacy.
  • hsCRP plays a role in heart failure, atrial fibrillation, hypertension, valve pathology, and stent-related complications.

Conclusions:

  • hsCRP testing is a valuable tool in both primary and secondary prevention of cardiovascular diseases.
  • Understanding hsCRP's role aids in risk stratification, treatment selection, and prognosis across various cardiovascular conditions.
  • Ongoing research investigates medications that target hsCRP concentration for potential therapeutic benefits.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
970
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
507